Alloimmune Thrombocytopenia in the Fetus and Newborn

Host: Lee P. Shulman, MD, FACMG, FACOG Guest: James B. Bussel, MD This program is no longer available for credit. Program Chairman: Roberto Romero, MD, DMedSci Chief, Perinatology Research Branch Division of Maternal-Fetal Medicine and Obstetrics Division of Intramural Research NICHD/NIH/DHHS Editor-in-Chief for Obstetrics The American Journal of Obstetrics and Gynecology As the platelet equivalent of hemolytic disease of the fetus and newborn, fetal and neonatal alloimmune thrombocytopenia (FNAIT) is an uncommon yet complex and life-threatening bleeding disorder that results from incompatibility between mother and baby for platelet-specific antigens. Despite relatively normal platelet function, in the setting of severe thrombocytopenia, intracranial hemorrhage is a consequence. Drs. Shulman and Bussel discuss advances in management strategies and concrete steps you can take to lower the risk and stop the progression of this disorder in your patients.

You can listen to Alloimmune Thrombocytopenia in the Fetus and Newborn online on Radio and Podcast. Open the player on this page to stream the available audio.

Alloimmune Thrombocytopenia in the Fetus and Newborn is an episode from Advances in Women's Health by ReachMD.

This episode is 00:18:30 long.

This episode was published on Nov 23, 2022.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Advances in Women's Health when more episodes are available from the podcast feed.